These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34219928)

  • 1. Hepatic manifestations of COVID-19 and effect of remdesivir on liver function in patients with COVID-19 illness.
    Aleem A; Mahadevaiah G; Shariff N; Kothadia JP
    Proc (Bayl Univ Med Cent); 2021 Mar; 34(4):473-477. PubMed ID: 34219928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis.
    Santenna C; Vidyasagar K; Amarneni KC; Ghanta SN; Sadasivam B; Pathan S; Padmavathi R
    Ther Adv Drug Saf; 2021; 12():20420986211042517. PubMed ID: 34594487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
    Sisay M
    Front Pharmacol; 2020; 11():791. PubMed ID: 32574236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefit of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Williamson BN; Feldmann F; Schwarz B; Meade-White K; Porter DP; Schulz J; van Doremalen N; Leighton I; Yinda CK; Pérez-Pérez L; Okumura A; Lovaglio J; Hanley PW; Saturday G; Bosio CM; Anzick S; Barbian K; Cihlar T; Martens C; Scott DP; Munster VJ; de Wit E
    Nature; 2020 Sep; 585(7824):273-276. PubMed ID: 32516797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case report study of the first five COVID-19 patients treated with remdesivir in France.
    Dubert M; Visseaux B; Isernia V; Bouadma L; Deconinck L; Patrier J; Wicky PH; Le Pluart D; Kramer L; Rioux C; Le Hingrat Q; Houhou-Fidouh N; Yazdanpanah Y; Ghosn J; Lescure FX
    Int J Infect Dis; 2020 Sep; 98():290-293. PubMed ID: 32619764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis.
    Sarfraz A; Sarfraz Z; Sanchez-Gonzalez M; Michel J; Michel G; Frontela O; Posada J; Cardona J; Angueira E
    Turk J Emerg Med; 2021; 21(2):43-50. PubMed ID: 33969238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Mini Review on Discovery and Synthesis of Remdesivir as an Effective and Promising Drug against COVID-19.
    Zarenezhad E; Behrouz S; Farjam M; Rad MNS
    Russ J Bioorg Chem; 2021; 47(3):609-621. PubMed ID: 34149273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The journey of remdesivir: from Ebola to COVID-19.
    Pardo J; Shukla AM; Chamarthi G; Gupte A
    Drugs Context; 2020; 9():. PubMed ID: 32547625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remdesivir therapy causing bradycardia in COVID-19 patients: Two case reports.
    Abdelmajid A; Osman W; Musa H; Elhiday H; Munir W; Al Maslamani MA; Elmekaty EZ
    IDCases; 2021; 26():e01254. PubMed ID: 34401329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-Induced Liver Injury in COVID-19 Patients: A Systematic Review.
    Sodeifian F; Seyedalhosseini ZS; Kian N; Eftekhari M; Najari S; Mirsaeidi M; Farsi Y; Nasiri MJ
    Front Med (Lausanne); 2021; 8():731436. PubMed ID: 34616757
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
    Richardson C; Bhagani S; Pollara G
    Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver tests abnormalities with licensed antiviral drugs for COVID-19: a narrative review.
    Casalini G; Giacomelli A; Antinori S
    Expert Opin Drug Saf; 2022 Dec; 21(12):1483-1494. PubMed ID: 36597859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
    Lim S; DeBruin DA; Leider JP; Sederstrom N; Lynfield R; Baker JV; Kline S; Kesler S; Rizza S; Wu J; Sharp RR; Wolf SM
    Mayo Clin Proc; 2020 Sep; 95(9):1946-1954. PubMed ID: 32861338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir Use in Low Weight, Premature, and Renally Impaired Infants With SARS-CoV-2 Infection in Sheikh Khalifa Medical City, UAE: Case Series.
    Mohammed W; Al Saqqa N; Ayanleke A
    Cureus; 2023 Jan; 15(1):e33591. PubMed ID: 36779110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remdesivir in treating hospitalized patients with COVID-19: A renewed review of clinical trials.
    Wu Z; Han Z; Liu B; Shen N
    Front Pharmacol; 2022; 13():971890. PubMed ID: 36160434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
    Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
    Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remdesivir administration for Japanese COVID-19 patients undergoing maintenance hemodialysis: a retrospective observation with six case reports.
    Ito J; Kimura M; Toya T; Isozumi K; Kawaji A; Isozaki Y; Fukagawa M
    Ren Replace Ther; 2022; 8(1):14. PubMed ID: 35433033
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.